Clinical trial
A Study of Tenecteplase for Restoration of Function in Dysfunctional…
NCT00396032 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00396032 |
|---|---|
| Title | A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters |
| Official title | A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters |
| Acronym | TROPICS 3 |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dysfunctional Hemodialysis Catheters |
| Intervention type | Drug |
| Interventions | placebo, tenecteplase |
| Enrollment | 150 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2008 |
| First posted | Nov 6, 2006 |
| Last update posted | Jun 3, 2010 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: